221 related articles for article (PubMed ID: 15337770)
1. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.
Kumar KG; Krolewski JJ; Fuchs SY
J Biol Chem; 2004 Nov; 279(45):46614-20. PubMed ID: 15337770
[TBL] [Abstract][Full Text] [Related]
2. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
[TBL] [Abstract][Full Text] [Related]
3. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis.
Kumar KG; Barriere H; Carbone CJ; Liu J; Swaminathan G; Xu P; Li Y; Baker DP; Peng J; Lukacs GL; Fuchs SY
J Cell Biol; 2007 Dec; 179(5):935-50. PubMed ID: 18056411
[TBL] [Abstract][Full Text] [Related]
4. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.
Kumar KG; Tang W; Ravindranath AK; Clark WA; Croze E; Fuchs SY
EMBO J; 2003 Oct; 22(20):5480-90. PubMed ID: 14532120
[TBL] [Abstract][Full Text] [Related]
5. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.
Watanabe N; Arai H; Nishihara Y; Taniguchi M; Watanabe N; Hunter T; Osada H
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4419-24. PubMed ID: 15070733
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
[TBL] [Abstract][Full Text] [Related]
7. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.
Bhattacharya S; HuangFu WC; Liu J; Veeranki S; Baker DP; Koumenis C; Diehl JA; Fuchs SY
J Biol Chem; 2010 Jan; 285(4):2318-25. PubMed ID: 19948722
[TBL] [Abstract][Full Text] [Related]
8. Ligand-independent pathway that controls stability of interferon alpha receptor.
Liu J; Plotnikov A; Banerjee A; Suresh Kumar KG; Ragimbeau J; Marijanovic Z; Baker DP; Pellegrini S; Fuchs SY
Biochem Biophys Res Commun; 2008 Mar; 367(2):388-93. PubMed ID: 18166147
[TBL] [Abstract][Full Text] [Related]
9. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.
Watanabe N; Arai H; Iwasaki J; Shiina M; Ogata K; Hunter T; Osada H
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11663-8. PubMed ID: 16085715
[TBL] [Abstract][Full Text] [Related]
11. Rotavirus NSP1 Requires Casein Kinase II-Mediated Phosphorylation for Hijacking of Cullin-RING Ligases.
Davis KA; Morelli M; Patton JT
mBio; 2017 Aug; 8(4):. PubMed ID: 28851847
[TBL] [Abstract][Full Text] [Related]
12. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
Zheng H; Qian J; Varghese B; Baker DP; Fuchs S
Mol Cell Biol; 2011 Feb; 31(4):710-20. PubMed ID: 21173164
[TBL] [Abstract][Full Text] [Related]
13. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
14. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
15. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.
Bhattacharya S; Qian J; Tzimas C; Baker DP; Koumenis C; Diehl JA; Fuchs SY
J Biol Chem; 2011 Jun; 286(25):22069-76. PubMed ID: 21540188
[TBL] [Abstract][Full Text] [Related]
16. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.
Kanemori Y; Uto K; Sagata N
Proc Natl Acad Sci U S A; 2005 May; 102(18):6279-84. PubMed ID: 15845771
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
Ragimbeau J; Dondi E; Alcover A; Eid P; Uzé G; Pellegrini S
EMBO J; 2003 Feb; 22(3):537-47. PubMed ID: 12554654
[TBL] [Abstract][Full Text] [Related]
18. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
[TBL] [Abstract][Full Text] [Related]
20. The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis.
Shimizu K; Fukushima H; Ogura K; Lien EC; Nihira NT; Zhang J; North BJ; Guo A; Nagashima K; Nakagawa T; Hoshikawa S; Watahiki A; Okabe K; Yamada A; Toker A; Asara JM; Fukumoto S; Nakayama KI; Nakayama K; Inuzuka H; Wei W
Sci Signal; 2017 Jan; 10(460):. PubMed ID: 28049764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
